Eduardo Vega, MD
Assistant Professor, Surgery
Biography
Dr. Vega, is a Hepato-Bilio-Pancreatic surgeon in the Department of Surgery at Saint Elizabeth Medical Center and Assistant Professor of Surgery BUSM. After completing residency in general surgery at Hospital Sotero del Rio, Santiago, Chile, Dr Vega served as Postdoctoral Fellow in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center from 2017 to 2019. Later, Dr Vega moved to Boston, Massachusetts to complete a fellowship in Minimally Invasive Hepato-Pancreato-Biliary (HPB) Surgery at Saint Elizabeth’s Medical Center of Tufts University. This experience lead to multiple publications that found innovative prognostic solutions for gallbladder cancer and pancreatic cancer which are being applied to clinical practice at MD Anderson and in Chile today.
Dr. Vega’s current research focuses on novel techniques/technologies to treat complex liver and pancreas cancer. In this context, he designed multiple innovative techniques for HPB disease that use 3D reconstruction software. This work has produced multiple publications in Annals Surgical Oncology and other peer-review journals. This reciprocal relationship between clinical surgery and research is a primary focus for Dr. Vega’s with an ultimate goal of applying innovative solutions to healthcare needs, especially in geographic areas with limited health resources.
Dr. Vega is currently a member of several national and international organizations including The Society for Surgery of the Alimentary Tract, Society of American Gastrointestinal and Endoscopic Surgeons and a combined member of the International Hepato-Pancreato-Biliary Association and the Americas Hepato-Pancreato-Biliary Association. In the future, Dr. Vega hopes to remain active as both an academic clinical surgeon and a translational researcher.
Publications
- Published on 3/17/2025
Serenari M, Rivera B, Kristjanpoller W, Vega EA. ASO Author Reflections: Surgical Wisdom in the Artificial Intelligence Era: Predicting Futility in Gallbladder Cancer. Ann Surg Oncol. 2025 Mar 17. PMID: 40097797.
Read at: PubMed - Published on 3/6/2025
Serenari M, Berti D, Rivera B, Newhook TE, Kristjanpoller W, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OM, Munoz C, Denbo J, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Anaya DA, Torzilli G, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN, Cescon M, Vega EA. Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multi-center Study. Ann Surg Oncol. 2025 Mar 06. PMID: 40050485.
Read at: PubMed - Published on 2/1/2025
Kawahara W, Rivera B, Roberts J, Huang C, Ladu A, Sorescu GP, Rabkin DJ, Kozyreva O, Rotellar F, Vega EA. Laparoscopic left hemihepatectomy using the Arantius-first approach after 90Y transarterial radioembolization and immunotherapy in a cirrhotic patient. Br J Surg. 2025 Feb 01; 112(2). PMID: 39913344.
Read at: PubMed - Published on 9/9/2024
Mitri J, Ajjour S, Panettieri E, Naamani HE, Mahmood SK, Vega EA. Disparate Tumor Characteristics and Survival Outcomes Between Squamous Cell and Adenocarcinoma Subtypes in Cholangiocarcinoma. Ann Surg Oncol. 2024 Nov; 31(12):7688-7692. PMID: 39251513.
Read at: PubMed - Published on 7/22/2024
Salirrosas O, Vega EA, Chirban AM, Harandi H, Cohen M, Anderson A, Bhargava R, Conrad C. ASO Author Reflections: The More We See the More We are Capable of Seeing: Optimal Minimally Invasive Management of de Novo Pancreas Cancer After Prior Laparoscopic Whipple for Pancreas Cancer. Ann Surg Oncol. 2024 Oct; 31(10):7072-7073. PMID: 39037525.
Read at: PubMed - Published on 7/3/2024
Salirrosas O, Vega EA, Chirban AM, Harandi H, Cohen M, Anderson A, Bhargava R, Conrad C. Laparoscopic Total Pancreatectomy After Laparoscopic Whipple. Ann Surg Oncol. 2024 Sep; 31(9):6193-6194. PMID: 38958808.
Read at: PubMed - Published on 6/1/2024
Salirrosas O, Vega EA, Panettieri E, Harandi H, Kozyreva O, Ghanta S, Conrad C. ASO Visual Abstract: Solid Pseudopapillary Tumor of the Pancreas-Is Enucleation Safe? Ann Surg Oncol. 2024 Jun; 31(6):4125-4126. PMID: 38619708.
Read at: PubMed - Published on 5/14/2024
Agudile EP, Vega EA, Salirrosas O, Agudile UM, Chirban AM, Lathan C, Sorescu GP, Odisio BC, Panettieri E, Conrad C. Temporal trends of health disparity in the utilization of curative-intent treatments for hepatocellular carcinoma: are we making progress? J Gastrointest Surg. 2024 Sep; 28(9):1392-1399. PMID: 38754809.
Read at: PubMed - Published on 4/18/2024
Vega EA, Rotellar F. ASO Author Reflections: Confronting Challenges with Creativity: Innovating Minimally Invasive Pancreatic Surgery. Ann Surg Oncol. 2024 Jul; 31(7):4698-4699. PMID: 38634963.
Read at: PubMed - Published on 4/16/2024
Salirrosas O, Vega EA, Panettieri E, Harandi H, Kozyreva O, Ghanta S, Conrad C. ASO Author Reflections: Pseudopapillary Tumor of the Pancreas: Getting the Dosing of Surgery Right. Ann Surg Oncol. 2024 Jul; 31(7):4700-4701. PMID: 38625600.
Read at: PubMed
View 85 more publications: View full profile at BUMC